Andrew Tutt
- Oncology top 0.02%
- PARP inhibition in cancer therapy 52
- HER2/EGFR in Cancer Research 16
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 28
- Cancer Genomics and Diagnostics 25
- Reproductive Medicine top 0.2%
- Molecular Biology top 0.1%
- DNA Repair Mechanisms 44
- CRISPR and Genetic Engineering 13
- Genetics top 0.1%
- BRCA gene mutations in cancer 44
-
- Advanced Breast Cancer Therapies 20
- Co-authors
- Alan AshworthChristopher J. LordNicholas C. TurnerGraeme C.M. SmithNuala McCabeJames CarmichaelJ. S. Reis-FilhoNiall M.B. Martin
- Journals
- Journal of Clinical Oncology (25 papers)Cancer Research (13 papers)Annals of Oncology (9 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Andrew Tutt
153 papers receiving 24.0k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 16.0k
- Cancer Research 5.9k
- Reproductive Medicine 2.3k
- Molecular Biology 14.6k
- Genetics 5.2k
Countries citing papers authored by Andrew Tutt
This map shows the geographic impact of Andrew Tutt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Tutt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Tutt more than expected).
Fields of papers citing papers by Andrew Tutt
This network shows the impact of papers produced by Andrew Tutt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Tutt. The network helps show where Andrew Tutt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew Tutt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 9 | |
| 3 | 2022 | 92 | |
| 4 | 2021 | 44 | |
| 5 | 2020 | 114 | |
| 6 | 2018 | 31 | |
| 7 | 2018 | 50 | |
| 8 | 2018 | 54 | |
| 9 | 2018 | 20 | |
| 10 | 2017 | 40 | |
| 11 | 2017 | 4 | |
| 12 | 2014 | 344 | |
| 13 | 2013 | 103 | |
| 14 | 2011 | 222 | |
| 15 | 2011 | 156 | |
| 16 | FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancerbreakdown → | 2010 | 544 |
| 17 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Intervalbreakdown → | 2010 | 745 |
| 18 | Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitionbreakdown → | 2006 | 977 |
| 19 | Predicting relapse in estrogen receptor (ER) positive breast cancer (luminal) subgroups treated with adjuvant tamoxifen | 2005 | 1 |
| 20 | 2004 | 3 |
About Andrew Tutt
Andrew Tutt is a scholar working on Oncology, Cancer Research, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 161 papers that have together received 24.5k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (52 papers), DNA Repair Mechanisms (44 papers), BRCA gene mutations in cancer (44 papers), Breast Cancer Treatment Studies (28 papers), Cancer Genomics and Diagnostics (25 papers), Advanced Breast Cancer Therapies (20 papers), HER2/EGFR in Cancer Research (16 papers) and CRISPR and Genetic Engineering (13 papers). The work is most often cited by research in Oncology (16.0k citations), Cancer Research (5.9k citations), Reproductive Medicine (2.3k citations), Molecular Biology (14.6k citations) and Genetics (5.2k citations). Andrew Tutt has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Alan Ashworth, Christopher J. Lord, Nicholas C. Turner, Alan Ashworth, Graeme C.M. Smith, Nuala McCabe, James Carmichael, J. S. Reis-Filho, Niall M.B. Martin and Stephen P. Jackson. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Breast Cancer Research and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.